Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis.

Journal Article

INTRODUCTION: Deep brain stimulation (DBS) surgery is an efficacious, underutilized treatment for Parkinson's disease (PD). Studies of DBS post-operative outcomes are often restricted to data from a single center and consider DBS in isolation. National estimates of DBS readmission and post-operative outcomes are needed, as are comparisons to commonly performed surgeries. METHODS: This study used datasets from the 2013 and 2014 Nationwide Readmissions Database (NRD). Our sample was restricted to PD patients discharged alive after hospitalization for DBS surgery. Descriptive analyses examined patient, clinical, hospital and index hospitalization characteristics. The all-cause, non-elective 30-day readmission rate after DBS was calculated, and logistic regression models were built to examine factors associated with readmission. Readmission rates for the most common surgical procedures were calculated and compared to DBS. RESULTS: There were 6058 DBS surgeries for PD in our sample, most often involving a male aged 65 and older, who lived in a high socioeconomic status zip code. DBS patients had an average of four comorbidities. With respect to outcomes, the majority of patients were discharged home (95.3%). Non-elective readmission was rare (4.9%), and was associated with socioeconomic status, comorbidity burden, and teaching hospital status. Much higher acute, non-elective readmission rates were observed for common procedures such as upper gastrointestinal endoscopy (16.2%), colonoscopy (14.0%), and cardiac defibrillator and pacemaker procedures (11.1%). CONCLUSION: Short-term hospitalization outcomes after DBS are generally favorable. Socioeconomic disparities in DBS use persist. Additional efforts may be needed to improve provider referrals for and patient access to DBS.

Full Text

Duke Authors

Cited Authors

  • Schneider, RB; Jimenez-Shahed, J; Abraham, DS; Thibault, DP; Mantri, S; Fullard, M; Burack, MA; Chou, KL; Spindler, M; Jermakowicz, WJ; D'Haese, P-F; York, MK; Kirk, JC; Schwalb, JM; Espay, AJ; Shih, LC; Simon, DK; Hunter, C; Crispo, JAG; Willis, AW; of the Parkinson Study Group Health Care Outcomes and Disparities Working Group (HCODWG) and the Registry to Advance DBS for PD (RAD-PD),

Published Date

  • January 2020

Published In

Volume / Issue

  • 70 /

Start / End Page

  • 96 - 102

PubMed ID

  • 31866156

Pubmed Central ID

  • 31866156

Electronic International Standard Serial Number (EISSN)

  • 1873-5126

Digital Object Identifier (DOI)

  • 10.1016/j.parkreldis.2019.11.023


  • eng

Conference Location

  • England